Preventing hospitalizations using molecular testing in home-based care with Barbara Andazola

Home Health 360: Presented By AlayaCare

Send us a text

In this episode, Barbara Andazola, VP of Clinical Practice, Strategy, and Programs at Amedisys, discusses the groundbreaking role of molecular testing in home health care. As an RN with over 27 years of nursing experience, Barbara shares how Amedisys is leveraging PCR (Polymerase Chain Reaction) testing to diagnose infections like UTIs, respiratory conditions, and even COVID-19 faster and more accurately at home. By identifying pathogens within hours, this technology not only improves patient outcomes but also helps prevent hospitalizations and antibiotic resistance. Barbara explores the challenges and rewards of integrating this advanced technology into home care, its impact on reducing healthcare costs, and the future possibilities for further innovation in diagnostics. Listen to this episode to learn how molecular testing is not only improving care but also driving efficiency, reducing healthcare costs, and shaping the future of home-based care—proving that innovation in home health care can lead to faster, smarter, and more precise treatment at home.
Related resources:

• Prevent hospitalizations and adverse events with AlayaCare's Client Intelligence Suite
• AlayaCare Cloud platform for Home Health providers

If you liked this episode and want to learn more about all things home-based care, you can explore all our episodes at alayacare.com/homehealth360.

Chapters

1. Innovative Home Health Molecular Testing (00:00:00)

2. Enhancing Care Through Advanced Molecular Testing (00:04:57)

3. Home Based Care Podcast Introduction (00:19:54)